Puma Biotechnology Inc (NAS:PBYI)
$ 7.69 -0.24 (-3.03%) Market Cap: 391.42 Mil Enterprise Value: 305.83 Mil PE Ratio: 16.02 PB Ratio: 3.05 GF Score: 53/100

Q1 2026 Puma Biotechnology Inc Earnings Call Transcript

May 07, 2026 / 08:30PM GMT
Release Date Price: $7.26 (-2.55%)
Operator

Good afternoon. My name is John, and I'll be your conference call operator today. (Operator Instructions)

As a reminder, this call is being recorded.

And I would now like to turn the conference call over to Mariann Ohanesian, Senior Director of IR for Puma Biotechnology. Thank you. You may begin your conference.

Mariann Ohanesian
Puma Biotechnology Inc - Investor Relations

Thank you, John. Good afternoon and welcome to Puma's conference call to discuss our results for the first quarter of 2026.

Joining me on the call today are Alan Auerbach, Chief Executive Officer, President and Chairman of the Board of Puma Biotechnology; Maximo Nogues, Chief Financial Officer; Heather Blaber, Senior Vice President of Marketing; and Roger Storm, Senior Vice President of Sales.

After the close today, Puma issued a news release detailing results for the first quarter of 2026. That news release, the slides that Alan and Roger will refer to and a webcast to this call are accessible via the homepage in investor sections of our website at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot